Literature DB >> 12623964

Enhancement of intrarenal angiotensinogen in Dahl salt-sensitive rats on high salt diet.

Hiroyuki Kobori1, Akira Nishiyama, Youichi Abe, L Gabriel Navar.   

Abstract

This study was performed to examine whether there is an inappropriate regulation of intrarenal angiotensinogen in Dahl-salt sensitive rats (DS) fed a high salt diet (HS). Dahl salt-resistant rats (DR) and DS were maintained on HS (8% NaCl) or low salt diet (LS, 0.3% NaCl) for 4 weeks. Systolic blood pressure (SBP), measured by tail-cuff plethysmography, was unaltered in DR (DR+HS, 127+/-3 mm Hg, n=5; DR+LS, 126+/-3, n=5); however, SBP was significantly increased in DS+HS (208+/-7, n=9) compared with DS+LS (134+/-2, n=5). HS suppressed plasma renin activity in both strains (0.7+/-0.2 ng of angiotensin I/mL per hour in DS+HS, 3.1+/-0.5 in DS+LS, 0.8+/-0.2 in DR+HS, 5.1+/-0.7 in DR+LS). Plasma angiotensinogen levels, measured by Western blot analysis, were also suppressed by HS in both strains (36 919+/-2170 integrated densitometric unit in DS+HS, 53 028+/-2752 in DS+LS, 44 722+/-1721 in DR+HS, 55782+/-3785 in DR+LS). However, kidney angiotensinogen levels were significantly increased in DS+HS (75 850+/-4171, integrated densitometric unit) compared with DS+LS (47 232+/-3470), DR+HS (44 748+/-8236), and DR+LS (42 504+/-4052). Urinary excretion of angiotensinogen, measured by radioimmunoassay of angiotensin I after incubation with excess renin, had a similar profile. Urinary excretion of angiotensinogen was significantly increased in DS+HS (2958+/-531 pmol/d) compared with DS+LS (56+/-4), DR+HS (31+/-12), and DR+LS (21+/-7). These data indicate that intrarenal angiotensinogen is enhanced in DS+HS, which is reflected by the increased urinary excretion of angiotensinogen. The results suggest that DS on HS have an inappropriate augmentation of intrarenal angiotensinogen, which may contribute to impaired sodium excretion during a high salt diet and the development of hypertension in this strain.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12623964      PMCID: PMC2572575          DOI: 10.1161/01.HYP.0000056768.03657.B4

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  35 in total

1.  Stage-specific differential activation of mitogen-activated protein kinases in hypertrophied and failing rat hearts.

Authors:  W Hayashida; Y Kihara; A Yasaka; K Inagaki; Y Iwanaga; S Sasayama
Journal:  J Mol Cell Cardiol       Date:  2001-04       Impact factor: 5.000

2.  Enhancement of angiotensinogen expression in angiotensin II-dependent hypertension.

Authors:  H Kobori; L M Harrison-Bernard; L G Navar
Journal:  Hypertension       Date:  2001-05       Impact factor: 10.190

3.  Renal perfusion in blacks: alterations caused by insuppressibility of intrarenal renin with salt.

Authors:  Deborah A Price; Naomi D L Fisher; M Cecilia Lansang; Radomir Stevanovic; Gordon H Williams; Norman K Hollenberg
Journal:  Hypertension       Date:  2002-08       Impact factor: 10.190

4.  Renin angiotensin system-dependent hypertrophy as a contributor to heart failure in hypertensive rats: different characteristics from renin angiotensin system-independent hypertrophy.

Authors:  Y Sakata; T Masuyama; K Yamamoto; R Doi; T Mano; T Kuzuya; T Miwa; H Takeda; M Hori
Journal:  J Am Coll Cardiol       Date:  2001-01       Impact factor: 24.094

5.  Urinary excretion of angiotensinogen reflects intrarenal angiotensinogen production.

Authors:  Hiroyuki Kobori; Lisa M Harrison-Bernard; L Gabriel Navar
Journal:  Kidney Int       Date:  2002-02       Impact factor: 10.612

6.  Kinetics of the human renin and human substrate reaction.

Authors:  A B Gould; D Green
Journal:  Cardiovasc Res       Date:  1971-01       Impact factor: 10.787

7.  Expression of angiotensinogen mRNA and protein in angiotensin II-dependent hypertension.

Authors:  Hiroyuki Kobori; Lisa M Harrison-Bernard; L Gabriel Navar
Journal:  J Am Soc Nephrol       Date:  2001-03       Impact factor: 10.121

8.  Angiotensinase A (aminopeptidase A): properties of chromatographically purified isoforms from human kidney.

Authors:  C M Herzig; W Schoeppe; J E Scherberich
Journal:  J Chromatogr       Date:  1992-11-13

9.  Prepubertal treatment with angiotensin receptor blocker causes partial attenuation of hypertension and renal damage in adult Dahl salt-sensitive rats.

Authors:  Hideaki Nakaya; Hiroyuki Sasamura; Mizuo Mifune; Ryoko Shimizu-Hirota; Mari Kuroda; Matsuhiko Hayashi; Takao Saruta
Journal:  Nephron       Date:  2002-08       Impact factor: 2.847

10.  Renoprotective effect of chronic adrenomedullin infusion in Dahl salt-sensitive rats.

Authors:  Toshio Nishikimi; Yosuke Mori; Naohiko Kobayashi; Kazuyoshi Tadokoro; Xin Wang; Kazumi Akimoto; Fumiki Yoshihara; Kenji Kangawa; Hiroaki Matsuoka
Journal:  Hypertension       Date:  2002-06       Impact factor: 10.190

View more
  111 in total

1.  Advanced oxidation protein products activate intrarenal renin-angiotensin system via a CD36-mediated, redox-dependent pathway.

Authors:  Wei Cao; Jie Xu; Zhan Mei Zhou; Guo Bao Wang; Fan Fan Hou; Jing Nie
Journal:  Antioxid Redox Signal       Date:  2012-07-30       Impact factor: 8.401

2.  SREBP-1 Mediates Angiotensin II-Induced TGF-β1 Upregulation and Glomerular Fibrosis.

Authors:  Tony N Wang; Xing Chen; Renzhong Li; Bo Gao; Zahraa Mohammed-Ali; Chao Lu; Victoria Yum; Jeffrey G Dickhout; Joan C Krepinsky
Journal:  J Am Soc Nephrol       Date:  2014-11-14       Impact factor: 10.121

Review 3.  Intratubular renin-angiotensin system in hypertension.

Authors:  L Gabriel Navar; Hiroyuki Kobori; Minolfa C Prieto; Romer A Gonzalez-Villalobos
Journal:  Hypertension       Date:  2011-01-31       Impact factor: 10.190

4.  Relationship between urinary angiotensinogen and salt sensitivity of blood pressure in patients with IgA nephropathy.

Authors:  Yoshio Konishi; Akira Nishiyama; Takashi Morikawa; Chizuko Kitabayashi; Mikiko Shibata; Masahiro Hamada; Masatsugu Kishida; Hirofumi Hitomi; Hideyasu Kiyomoto; Takenori Miyashita; Nozomu Mori; Maki Urushihara; Hiroyuki Kobori; Masahito Imanishi
Journal:  Hypertension       Date:  2011-06-13       Impact factor: 10.190

5.  Enhanced angiotensin-converting enzyme activity and systemic reactivity to angiotensin II in normotensive rats exposed to a high-sodium diet.

Authors:  Sandra Crestani; Arquimedes Gasparotto Júnior; Maria C A Marques; Jennifer C Sullivan; R Clinton Webb; J Eduardo da Silva-Santos
Journal:  Vascul Pharmacol       Date:  2013-12-07       Impact factor: 5.773

6.  Divergent localization of angiotensinogen mRNA and protein in proximal tubule segments of normal rat kidney.

Authors:  Masumi Kamiyama; Kristina M Farragut; Michelle K Garner; L Gabriel Navar; Hiroyuki Kobori
Journal:  J Hypertens       Date:  2012-12       Impact factor: 4.844

Review 7.  Metabolic syndrome and endothelial dysfunction.

Authors:  Alessia Fornoni; Leopoldo Raij
Journal:  Curr Hypertens Rep       Date:  2005-04       Impact factor: 5.369

8.  Transcriptional regulation of heterogeneous nuclear ribonucleoprotein K gene expression.

Authors:  Liqing He; Xiaochang Xue; Zhengjun Wang; Entai Hou; Yong Liu; Mingyu Liang; Yingqi Zhang; Zhongmin Tian
Journal:  Biochimie       Date:  2014-12-10       Impact factor: 4.079

Review 9.  Vascular insulin resistance: a potential link between cardiovascular and metabolic diseases.

Authors:  Ivonne Hernandez Schulman; Ming-Sheng Zhou
Journal:  Curr Hypertens Rep       Date:  2009-02       Impact factor: 5.369

10.  Effects of tempol on renal angiotensinogen production in Dahl salt-sensitive rats.

Authors:  Hiroyuki Kobori; Akira Nishiyama
Journal:  Biochem Biophys Res Commun       Date:  2004-03-12       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.